Akanda (NASDAQ:AKAN) Upgraded at Wall Street Zen

Akanda (NASDAQ:AKAN) was upgraded by investment analysts at Wall Street Zen from a “strong sell” rating to a “sell” rating in a research report issued to clients and investors on Saturday.

Separately, Weiss Ratings cut shares of Akanda from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Monday, May 18th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the company presently has a consensus rating of “Sell”.

Akanda Price Performance

Shares of AKAN opened at $7.73 on Friday. Akanda has a twelve month low of $2.30 and a twelve month high of $209.02. The company’s fifty day simple moving average is $14.93 and its 200-day simple moving average is $10.54.

Akanda (NASDAQ:AKAN) last issued its quarterly earnings results on Tuesday, June 9th. The company reported ($317.90) earnings per share for the quarter.

About Akanda

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.